As is well known, in the period between 1978 and 1997 had place the process of development and consolidation of Bioethics. In that time period were issued a number of regulations, recommendations and laws. Indeed, in vitro fertilization techniques, genetic engineering, transplantation, prenatal diagnosis, etc, which have now a great social impact, became part of the service portfolios of leading university hospitals in the western world .
In this era saw the publication of the Belmont Report, the first success of human in vitro fertilization and embryo transfer, and significant progress in prenatal diagnosis and the genetic engineering. In addition, at the institutional level, created the International Group for the Study of Bioethics, the European Association of Centres of Medical Ethics and the French National Consultative Committee.
Without doubt, the most profound change in the physician - patient relationship during the last thirty years has been the recognition of the individual patient's autonomous moral agent. That is, the patient has the right to be informed properly, to refuse treatment offered to him if it is not compatible with their scale of values. The practical recognition of this fundamental right clashed with traditional training in Hippocratic which the physician - patient, known as asymmetric, was established with the understanding that the doctor knew what he suited the patient and this, in principle, but had to obey the doctor's instructions and requirements.
Molecular Biology and Microelectronics, and technology, represent, together with increased knowledge, an increase of power, with the danger that its use is virtually universal reach. The factors involved in these high technologies are certainly dangerous to the extent it does not take into account the social, since, if so, dynamics generated by the technology reverses the relationship between the means and ends, tending to impose the means as ends, with the risks resulting from the removal of the elements of responsibility, both in the field of individual consciousness as collective powers
The new biotechnologies, particularly those derived from advances in molecular and cellular biology (genetic engineering, manipulation of the reproductive process, etc.) are inroads into large areas of human activity, bringing with it promises of wealth and welfare but also arousing suspicions and fears, not only to its possible misuse, but as representatives of "Intrinsic aggressiveness" of modern technologies. This is due in large part to the manipulation of the basis of life processes removes deep symbols and intuitions that are at the root of worldviews of many cultures.
Various stakeholders (professionals, industries, governments, environmentalists, consumer groups, religions, etc.) Are actively involved in the controversy over biotechnology applications, which should eventually lead to some form of citizen participation in the design and control of these and other scientific applications that have much capacity to change social and economic relations globally.
strengthen ethics and legal regulation of biotechnology in general, and research in particular is a necessity, not only in Western countries but also in developing countries. Biotechnology and research in developed countries require that new treatments are contrasted against the current best. But even the addition of these points in the Declarations and International Legal Norms improve by itself, the picture. The key is people, to adapt international standards to local circumstances, develop and enforce national codes, to promote ethics committees and implement processes for making ethical decisions in research.
Well, when are at stake bases which underlie our heritage, when we see the potential of injury to the right to privacy when there is reason to believe any discriminatory conduct based on genetic information, when genetic engineering has provided scientists with instruments capable of altering the genome by the addition of these amendments pass on to future generations is increasingly necessary to enact a statutory provision, away from the Biotechnology partial regulation, establish a systematic and adequate regulatory framework in which all
Medical Writing Published in the Tuesday, April 12, 2011. Number 1437. Year VII.
In this era saw the publication of the Belmont Report, the first success of human in vitro fertilization and embryo transfer, and significant progress in prenatal diagnosis and the genetic engineering. In addition, at the institutional level, created the International Group for the Study of Bioethics, the European Association of Centres of Medical Ethics and the French National Consultative Committee.
Without doubt, the most profound change in the physician - patient relationship during the last thirty years has been the recognition of the individual patient's autonomous moral agent. That is, the patient has the right to be informed properly, to refuse treatment offered to him if it is not compatible with their scale of values. The practical recognition of this fundamental right clashed with traditional training in Hippocratic which the physician - patient, known as asymmetric, was established with the understanding that the doctor knew what he suited the patient and this, in principle, but had to obey the doctor's instructions and requirements.
Molecular Biology and Microelectronics, and technology, represent, together with increased knowledge, an increase of power, with the danger that its use is virtually universal reach. The factors involved in these high technologies are certainly dangerous to the extent it does not take into account the social, since, if so, dynamics generated by the technology reverses the relationship between the means and ends, tending to impose the means as ends, with the risks resulting from the removal of the elements of responsibility, both in the field of individual consciousness as collective powers
The new biotechnologies, particularly those derived from advances in molecular and cellular biology (genetic engineering, manipulation of the reproductive process, etc.) are inroads into large areas of human activity, bringing with it promises of wealth and welfare but also arousing suspicions and fears, not only to its possible misuse, but as representatives of "Intrinsic aggressiveness" of modern technologies. This is due in large part to the manipulation of the basis of life processes removes deep symbols and intuitions that are at the root of worldviews of many cultures.
Various stakeholders (professionals, industries, governments, environmentalists, consumer groups, religions, etc.) Are actively involved in the controversy over biotechnology applications, which should eventually lead to some form of citizen participation in the design and control of these and other scientific applications that have much capacity to change social and economic relations globally.
strengthen ethics and legal regulation of biotechnology in general, and research in particular is a necessity, not only in Western countries but also in developing countries. Biotechnology and research in developed countries require that new treatments are contrasted against the current best. But even the addition of these points in the Declarations and International Legal Norms improve by itself, the picture. The key is people, to adapt international standards to local circumstances, develop and enforce national codes, to promote ethics committees and implement processes for making ethical decisions in research.
Well, when are at stake bases which underlie our heritage, when we see the potential of injury to the right to privacy when there is reason to believe any discriminatory conduct based on genetic information, when genetic engineering has provided scientists with instruments capable of altering the genome by the addition of these amendments pass on to future generations is increasingly necessary to enact a statutory provision, away from the Biotechnology partial regulation, establish a systematic and adequate regulatory framework in which all
Medical Writing Published in the Tuesday, April 12, 2011. Number 1437. Year VII.
0 comments:
Post a Comment